PDF herunterladen
Synlett 2018; 29(02): 246-250
DOI: 10.1055/s-0036-1589115
letter
© Georg Thieme Verlag Stuttgart · New York

l-Phenylalanine Triflate as Organocatalyst for Divergent ­Approaches to Trisubstituted Hexahydroimidazo[1,2-a]pyridine and 1,4-Diazepane Derivatives

Jun Jiang
a   National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   eMail: lijianjun@zjut.edu.cn
b   Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, P. R. of China
,
Miao Zhang
a   National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   eMail: lijianjun@zjut.edu.cn
,
Wen-Biao Wu
b   Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, P. R. of China
,
Hai-Bo Lu
a   National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   eMail: lijianjun@zjut.edu.cn
b   Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, P. R. of China
,
Yu-Long Shi
b   Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, P. R. of China
,
Jian-Jun Li*
a   National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   eMail: lijianjun@zjut.edu.cn
b   Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, P. R. of China
› InstitutsangabenWe are grateful to the National Natural Science Foundation of China (No. 21776254 and 21406203) for financial support.
Weitere Informationen

Publikationsverlauf

Received: 02. Juli 2017

Accepted after revision: 11. September 2017

Publikationsdatum:
11. Oktober 2017 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik


Abstract

The convergent synthesis of two biologically significant classes of trisubstituted hexahydroimidazo[1,2-a]pyridine and 1,4-diazepane derivatives from readily available aromatic aldehydes, ketones, and ethane-1,2-diamine is reported. This protocol is promoted by the highly effective l-phenylalanine triflate catalyst through intermolecular annulation, and tolerates a variety of functional groups with excellent yields.

Key words

multicomponent reactions - nitrogen heterocycles - imidazopyridines - diazepanes - organocatalysis - phenylalanine triflate

Supporting Information

 

  • References and Notes

  • 3 Okubo T. Yoshikawa R. Chaki S. Okuyama S. Nakazato A. Bioorg. Med. Chem. 2004; 12: 423
    CrossrefSuche in Google Scholar
  • 4 Almirante L. Polo L. Mugnaini A. Provinciali E. Rugarli P. Biancotti A. Gamba A. Murmann W. J. Med. Chem. 1965; 8: 305
    CrossrefSuche in Google Scholar
  • 6 Kukla MJ. Breslin HJ. J. Org. Chem. 1987; 52: 5046
    CrossrefSuche in Google Scholar
  • 7 Márton-Merész M. Zára-Kaczián E. Boros S. Mátyus P. J. Heterocycl. Chem. 1997; 34: 1033
    CrossrefSuche in Google Scholar
  • 10 Wang R.-L. Zhu P. Lu Y. Huang F.-P. Hui X.-P. Adv. Synth. Catal. 2013; 355: 87
    CrossrefSuche in Google Scholar
  • 12 Li J. He P. Yu C. Tetrahedron 2012; 68: 4138
    CrossrefSuche in Google Scholar
  • 13 Trisubstituted hexahydroimidazo[1,2-a] pyridines 4a–r; General ProcedureThe appropriate aldehyde (1.0 mmol), ketone (2.5 mmol), H2N(CH2)2NH2 (1.0 mmol), and MeOH (5.0 mL) were mixed with LPAT (10 mol%), and the mixture was refluxed for 24 h. The solvent was evaporated and the residue was crystallized.5,7,8a-Triphenyl-1,2,3,7,8,8a-hexahydroimidazo[1,2-a]pyridine (4a)White solid; yield: 320.5 mg (91%); mp 133.5–134.5 °C. 1H NMR (400 MHz, CDCl3): δ = 7.68–7.61 (m, 4 H), 7.39–7.16 (m, 11 H), 4.97 (s, 1 H), 3.62–3.56 (m, 1 H), 3.18–3.05 (m, 2 H), 3.00–2.94 (m, 2 H), 2.45 (dd, J = 12.4, 5.6 Hz, 1 H), 2.17 (s, 1 H), 1.87 (t, J = 12.4 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 145.7, 145.4, 144.9, 139.7, 128.4, 128.3, 127.9, 127.4, 127.2, 126.2, 125.9, 107.5, 80.8, 52.5, 44.4, 41.8, 39.4. MS (ESI): m/z = 353.2 [M + 1]+.7-(3,4-Dimethylphenyl)-5,8a-diphenyl-1,2,3,7,8,8a-hexahydroimidazo[1,2-a]pyridine (4c)Pale-yellow solid; yield: 353.6 mg (93%); mp 122.8–123.6 °C. 1H NMR (400 MHz, CDCl3): δ = 7.64 (dd, J = 16.0, 7.2 Hz, 4 H), 7.38–7.27 (m, 6 H), 7.05–6.96 (m, 3 H), 4.96 (s, 1 H), 3.61–3.55 (m, 1 H), 3.17–3.04 (m, 2 H), 3.00–2.89 (m, 2 H), 2.42 (dd, J = 12.0, 5.6 Hz, 1 H), 2.24 (s, 3 H), 2.23 (s, 3 H), 2.13 (s, 1 H), 1.86 (t, J = 12.4 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 145.4, 145.0, 142.8, 139.7, 136.5, 134.4, 129.7, 128.8, 128.4, 128.2, 127.8, 127.4, 127.2, 126.0, 124.8, 108.1, 80.8, 52.5, 44.4, 41.7, 39.0, 20.1, 19.6. MS (ESI): m/z = 381.2 [M + 1]+. HRMS-ESI: m/z calcd for C27H29N2: 381.2325; found: 381.2345.
  • 14 Fujioka H. Murai K. Kubo O. Ohba Y. Kita Y. Org. Lett. 2007; 9: 1687
    CrossrefPubMedSuche in Google Scholar
  • 16 1,4-Diazepane 6a–h; General Procedure Aromatic aldehyde (1.0 mmol), ethyl acetoacetate (1.2 mmol), H2N(CH2)2NH2 (1.0 mmol), and toluene (5.0 mL) were mixed with LPAT (10 mol%), and the mixture was refluxed for 24 h. The solvent was evaporated under reduced pressure to afford the crude compound, which was purified by flash chromatography (silica gel).Ethyl (2Z)-(7-Phenyl-1,4-diazepan-5-ylidene)acetate (6a)Yellow oil; yield: 161.2 mg (62%). 1H NMR (400 MHz, CDCl3): δ = 8.90 (br s, 1 H), 7.35–7.24 (m, 5 H), 4.45 (s, 1 H), 4.09 (q, J = 7.2 Hz, 2 H), 3.75 (d, J = 10.0 Hz, 1 H), 3.62–3.55 (m, 1 H), 3.42–3.35 (m, 1 H), 3.16 (dd, J = 12.8, 4.4 Hz, 1 H), 2.98–2.82 (m, 2 H), 2.34 (d, J = 14.4 Hz, 1 H), 1.93 (br s, 1 H), 1.25 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.6, 165.4, 145.0, 128.8, 127.7, 126.4, 82.5, 62.8, 58.7, 51.0, 46.5, 46.2, 14.9. MS (ESI): m/z = 261.0 [M + 1]+.
  • 17 CCDC 1422263 contains the supplementary crystallographic data for compound 4a. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.